Arrhythmogenic cardiomyopathy: a biventricular disease in search of a cure.

[1]  R. Hauer,et al.  End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum. , 2013, Heart rhythm.

[2]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy. , 2012, Circulation. Arrhythmia and electrophysiology.

[3]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2012, Herz.

[4]  S. Rizzo,et al.  Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. , 2012, Cardiovascular research.

[5]  W. Birchmeier,et al.  Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. , 2012, Cardiovascular research.

[6]  D. Corrado,et al.  Pathophysiology of arrhythmogenic cardiomyopathy , 2012, Nature Reviews Cardiology.

[7]  Nicola Elvassore,et al.  Role of YAP/TAZ in mechanotransduction , 2011, Nature.

[8]  G. Thiene,et al.  Arrhythmogenic Cardiomyopathy: Transgenic Animal Models Provide Novel Insights Into Disease Pathobiology , 2011, Circulation. Cardiovascular genetics.

[9]  G. Breithardt,et al.  Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. , 2011, Journal of the American College of Cardiology.

[10]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy: what's in a name? From a congenital defect (dysplasia) to a genetically determined cardiomyopathy (dystrophy). , 2010, The American journal of cardiology.

[11]  K. Bushby,et al.  Interventions for muscular dystrophy: molecular medicines entering the clinic , 2009, The Lancet.

[12]  A. Moorman,et al.  Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy , 2009, The Journal of experimental medicine.

[13]  R. Schwartz,et al.  Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy , 2009, Circulation research.

[14]  S. Russell,et al.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[15]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[16]  Maurizio Schiavon,et al.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.

[17]  G. Breithardt,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy , 2005, Herz Kardiovaskuläre Erkrankungen.

[18]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[19]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[20]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[21]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[22]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[23]  N. Reichek,et al.  Different effects of prolonged exercise on the right and left ventricles. , 1990, Journal of the American College of Cardiology.